| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/14/1998 | EP0818539A1 Methylsulfomycin I, a process for its production and its use |
| 01/14/1998 | EP0818536A1 Dna molecule relating to suppression of gene expression and novel protein |
| 01/14/1998 | EP0818533A2 Novel isoform gene for focal adhesion protein paxillin |
| 01/14/1998 | EP0818466A2 Purified, biologically active bacterially produced recombinant human CSF-1 |
| 01/14/1998 | EP0818464A1 Methylsulfomycin l, a process for its production and its use |
| 01/14/1998 | EP0818462A1 Peptide and a method of obtaining it |
| 01/14/1998 | EP0818453A1 Benzothiophene compounds and methods of use |
| 01/14/1998 | EP0818204A2 Stabilized albumin-free recombinant factor VIII preparation having a low sugar contant |
| 01/14/1998 | EP0817967A1 Insulin mimetic and enhancer assay |
| 01/14/1998 | EP0817861A1 Gene transfer into the kidney |
| 01/14/1998 | EP0817859A1 Novel recombinant dna vectors for gene therapy |
| 01/14/1998 | EP0817858A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 01/14/1998 | EP0817853A1 Infectious dna clone of the tick-borne encephalitis (tbe) virus; recombinant vaccine derived from the said clone and production of the said vaccine; and a pharmaceutical product containing a replicable nucleic acid |
| 01/14/1998 | EP0817847A1 Il-17 receptor |
| 01/14/1998 | EP0817846A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 01/14/1998 | EP0817845A1 Conditional expression system |
| 01/14/1998 | EP0817844A1 T-cell receptors and their use in therapeutic and diagnostic methods |
| 01/14/1998 | EP0817842A1 Antibody to human betacellulin and use thereof |
| 01/14/1998 | EP0817839A1 Human dnase |
| 01/14/1998 | EP0817801A1 Antibody to the syncytiotrophoblast antigen r80k and use thereof |
| 01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
| 01/14/1998 | EP0817798A1 Nucleotide and protein sequences of lats genes and methods based thereon |
| 01/14/1998 | EP0817797A1 Glycopeptide antibiotic derivatives |
| 01/14/1998 | EP0817796A1 Cyclic peptide nuclei and derivatives thereof |
| 01/14/1998 | EP0817795A1 Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor |
| 01/14/1998 | EP0817792A1 Compositions for the diagnosis, prevention, and treatment of tumor progression |
| 01/14/1998 | EP0817791A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis |
| 01/14/1998 | EP0817778A1 Reversible protease inhibitors |
| 01/14/1998 | EP0817770A1 Nonpeptides as tachykinin antagonists |
| 01/14/1998 | EP0817650A1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 01/14/1998 | EP0817649A1 Limbic system-associated membrane protein and dna |
| 01/14/1998 | EP0817648A1 Vascular endothelial cell growth factor antagonists |
| 01/14/1998 | EP0817647A1 Treatment for verotoxin-producing escherichia coli |
| 01/14/1998 | EP0817646A2 Methods of treating inflammation and compositions therefor |
| 01/14/1998 | EP0817645A1 Method for treatment of benign prostatic hypertrophy |
| 01/14/1998 | EP0817644A1 Treatment of papillomavirus-associated lesions using interleukin-12 |
| 01/14/1998 | EP0817643A1 Compounds and compositions for delivering active agents |
| 01/14/1998 | EP0817642A1 $g(b)-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS |
| 01/14/1998 | EP0817638A2 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers |
| 01/14/1998 | EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 01/14/1998 | EP0817622A1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application |
| 01/14/1998 | EP0817619A1 Novel "burst-free" sustained release poly-(lactide/glycolide) mi crospheres |
| 01/14/1998 | EP0817614A1 Stable protein:phospholipid compositions and methods------------ |
| 01/14/1998 | EP0667916B1 Crf binding protein |
| 01/14/1998 | EP0661987B1 Morphogen-induced liver regeneration |
| 01/14/1998 | EP0594782B1 Syringe system |
| 01/14/1998 | EP0429570B1 Osteoinductive compositions |
| 01/14/1998 | EP0394277B1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/14/1998 | CN1170435A Regulation of neural stem cell proliferation |
| 01/14/1998 | CN1170434A In vitro Induction of dopaminergic cells |
| 01/14/1998 | CN1170414A Human neutrophil elastase inhibitors |
| 01/14/1998 | CN1170413A Process for preparing intermediates of inhibitors of enkephalinase and angiotensin coverting enzyme and intermediates thereof |
| 01/14/1998 | CN1170409A 2, 3-diketopiperazine derivative of salt thereof |
| 01/14/1998 | CN1170361A Therapeutic perparation for inhalation containing parathyroid hormone, PTH |
| 01/14/1998 | CN1170000A Heri factor coupled material, its preparation, composition containing it and application |
| 01/13/1998 | US5708163 Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof |
| 01/13/1998 | US5708157 Secreted proteins and polynucleotides encoding them |
| 01/13/1998 | US5708156 Epidermal growth factor receptor-like gene product and its uses |
| 01/13/1998 | US5708149 Method for producing purified recombinant Haemophilus influenzae transferrin binding proteins |
| 01/13/1998 | US5708148 Mutants of escherichia coli cells, denaturing polypeptides, refolding and incubation |
| 01/13/1998 | US5708147 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 01/13/1998 | US5708145 Antibodies |
| 01/13/1998 | US5708143 Protocadherin materials and methods |
| 01/13/1998 | US5708141 Neutrophil inhibitors |
| 01/13/1998 | US5708136 Polypetides which bind to human MDM2 |
| 01/13/1998 | US5708135 Cyclic peptide analogs of somatostatin |
| 01/13/1998 | US5708025 By inducing production of fetal hemoglobins by administering specified aryl acids, derivatives, salts |
| 01/13/1998 | US5708016 Pseudopeptides derived from neurokinins |
| 01/13/1998 | US5708004 Retroviral protease inhibitors |
| 01/13/1998 | US5707991 N-acylpyrrolidines and medicaments for the treatment or prevention of disorders linked to CKK and to gastrin |
| 01/13/1998 | US5707980 Administering 1a,25-dihydroxyvitamin d4 to patient |
| 01/13/1998 | US5707968 Administering beta-casein or derivative to prevent influenza infections |
| 01/13/1998 | US5707966 Peptide derivatives |
| 01/13/1998 | US5707964 Hormone-toxin conjugate, gonadotropin-releasing hormone receptors |
| 01/13/1998 | US5707963 Estrogen, diethylstibesterol, hydrocortisone and human chorionic gonadotropin for cells, contacting with peptides and inhibiting growth factor stimulated growth |
| 01/13/1998 | US5707962 Compositions with enhanced osteogenic potential, method for making the same and therapeutic uses thereof |
| 01/13/1998 | US5707867 Antiviral compounds |
| 01/13/1998 | US5707866 Dna with rna for antisense oligomers |
| 01/13/1998 | US5707864 Dna comprisinf nucleic acid encoding of mutant htlv matrix |
| 01/13/1998 | US5707863 Tumor suppressor gene merlin |
| 01/13/1998 | US5707855 CEMA cationic peptide and polynucleotides encoding cEMA |
| 01/13/1998 | US5707835 Compounds with high endoribonuclease activity with hybridizing regions |
| 01/13/1998 | US5707832 Culturing eukaryotic cells in medium supplemented with a sulfated polysaccharide |
| 01/13/1998 | US5707829 DNA sequences and secreted proteins encoded thereby |
| 01/13/1998 | US5707826 Transpeptidation, replacing terminal portion of peptide sequence with another sequence, forming amide at c-terminal position in one step |
| 01/13/1998 | US5707815 Polypeptides produced bby expression of heterologous nucleic acid in cells and encoded by dna and hybridize |
| 01/13/1998 | US5707814 CD8+ cell antiviral factor |
| 01/13/1998 | US5707810 Method of diagnosing renal tissue damage or disease |
| 01/13/1998 | US5707805 Assay for detecting keratinocyte growth factor (KGF) and its activity |
| 01/13/1998 | US5707795 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 01/13/1998 | US5707657 Regenerating, repairing organs |
| 01/13/1998 | US5707648 Oil phase, mixture of surfactants, polyoxyethylene glycol, peptides, proteins, polysaccharides |
| 01/13/1998 | US5707642 Method of treating fibromyalgia with relaxin |
| 01/13/1998 | US5707641 Formulations comprising therapeutically-active proteins or polypeptides |
| 01/13/1998 | US5707632 Immunology |
| 01/13/1998 | US5707627 Methods and compositions for the direct concentrated delivery of passive immunity |
| 01/13/1998 | US5707624 Administering antibodies |
| 01/13/1998 | US5707622 Methods for treating ulcerative colitis |
| 01/13/1998 | US5707621 Supression of nephritis-induced protein excretion by anti-IL-8 |
| 01/13/1998 | US5707616 Method for treating or preventing gastrointestinal disease with epithelium-derived T-cell factor |